Horn L - Search Results

1

Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.

Heist RS, Guarino MJ, Masters G, Purcell WT, Starodub AN, Horn L, Scheff RJ, Bardia A, Messersmith WA, Berlin J, Ocean AJ, Govindan SV, Maliakal P, Mudenda B, Wegener WA, Sharkey RM, Goldenberg DM, Camidge DR. Heist RS, et al. Among authors: horn l. J Clin Oncol. 2017 Aug 20;35(24):2790-2797. doi: 10.1200/JCO.2016.72.1894. Epub 2017 May 26. J Clin Oncol. 2017. PMID: 28548889 Clinical Trial.

2

Evarts A. Graham and the first pneumonectomy for lung cancer.

Horn L, Johnson DH. Horn L, et al. J Clin Oncol. 2008 Jul 1;26(19):3268-75. doi: 10.1200/JCO.2008.16.8260. J Clin Oncol. 2008. PMID: 18591561 No abstract available.

3

A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.

Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. Horn L, et al. J Thorac Oncol. 2009 Apr;4(4):527-33. doi: 10.1097/JTO.0b013e31819c7daf. J Thorac Oncol. 2009. PMID: 19240650 Free PMC article. Clinical Trial.

4

Angiogenesis in the treatment of non-small cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):206-17. doi: 10.1513/pats.200807-066LC. Proc Am Thorac Soc. 2009. PMID: 19349490 Free PMC article. Review.

5

Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Clin Lung Cancer. 2009 Mar;10 Suppl 1(Suppl 1):S7-16. doi: 10.3816/CLC.2009.s.002. Clin Lung Cancer. 2009. PMID: 19362948 Free PMC article. Review.

6

Targeting the eicosanoid pathway in non-small-cell lung cancer.

Horn L, Backlund M, Johnson DH. Horn L, et al. Expert Opin Ther Targets. 2009 Jun;13(6):675-88. doi: 10.1517/14728220902915567. Epub 2009 May 2. Expert Opin Ther Targets. 2009. PMID: 19409031 Free PMC article. Review.

7

Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.

Horn L, Sandler A. Horn L, et al. Clin Cancer Res. 2009 Aug 15;15(16):5040-8. doi: 10.1158/1078-0432.CCR-09-0520. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671872 Free PMC article. Review.

8

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501.

Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH. Horn L, et al. J Clin Oncol. 2009 Dec 10;27(35):6006-11. doi: 10.1200/JCO.2009.23.7545. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826110 Free PMC article. Clinical Trial.

9

Update on new drugs in small cell lung cancer.

Horn L, Castellanos EL, Johnson DH. Horn L, et al. Expert Opin Investig Drugs. 2011 Apr;20(4):441-5. doi: 10.1517/13543784.2011.553185. Expert Opin Investig Drugs. 2011. PMID: 21395484 Review.

10

A phase II study of carboplatin and irinotecan in extensive stage small-cell lung cancer.

Horn L, Zhao Z, Sandler A, Johnson D, Shyr Y, Wolff S, Devore RF, Laskin J. Horn L, et al. Clin Lung Cancer. 2011 May;12(3):161-5. doi: 10.1016/j.cllc.2011.03.013. Epub 2011 Apr 27. Clin Lung Cancer. 2011. PMID: 21663858 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,326 results

Search Page